Biotech Startups

Fluidx Medical Technology develops embolic devices for use in embolization procedures that are designed to be easy to use, controllable, visible, and durable. The company serves interventional physicians and patients requiring embolization treatments.

1 investor

Fluigent develops, manufactures, and supports pressure-based fluid control systems and components for microfluidics, serving research applications such as droplets, cell biology, and particle studies. It also offers OEM components, system development, and engineering services for industrial instrument developers through its Fluigent industrial line.

1 investor

Fluorobiotech develops molecular enzymes—using its patented SelfPrep technology—for in vitro transcription, mRNA synthesis, and transcriptomics, serving researchers, developers, and manufacturers with molecular biology reagents. The company produces ISO 13485-certified enzymes at scales from micrograms to grams for both preclinical studies and commercial volumes.

1 investor

FlutteSpace is an AI-powered medical technology company that reimagines radiology workflows by combining machine learning with radiologist expertise. The startup serves radiologists and healthcare providers globally to improve diagnostic quality and healthcare accessibility.

1 investor

FlyUP Bio develops black soldier fly (Hermetia illucens) farming technology to convert food-industry and agricultural by-products and biowaste into animal-feed proteins, lipids, and organic fertilizer (frass). A spinoff of the Ruđer Bošković Institute, it currently sells live and dried BSF larvae, primarily as pet food, in Croatia.

1 investor

Focal MD, founded in 2022, supports and advances medical innovation through global strategic investments. The company operates in the medical technology and innovation space.

1 investor

Follica is developing a regenerative platform for hair growth, combining a skin disruption approach with an at-home treatment device. The company is focused on treatments for hair loss and hair regeneration.

1 investor

Fontana Biosciences is a life sciences company based in Boston. The page provides only contact information and does not describe the company's specific products or focus.

1 investor

Food Brewer develops cultured cocoa and coffee, along with cocoa and coffee alternatives, as a way to secure food resources. The company works in cell-cultured food production within the food technology sector.

1 investor

Forage Evo develops a bacterial strain positioned as a lab assistant for molecular biology workflows, offering faster plasmid assembly to colonies (under 7 hours) than E. coli. It targets researchers and labs in the biotechnology and life sciences space.

1 investor

ForeLight develops indoor, LED-driven photobioreactor systems for producing microalgae, aiming to lower the energy, labor, and capital costs of indoor cultivation. Its platform targets agricultural raw material markets including food ingredients, pharmaceuticals, animal and pet feed, and cosmetics.

1 investor

Forever Harvest is a cellular horticulture company that grows fruit and nut cells in controlled environments, developing plant cell lines and growth media to produce custom fruit and nut ingredients for industry partners. It offers on-demand ingredient supply with tailored functional and flavour profiles, produced without genetic modification.

1 investor

Forge Therapeutics operates a drug discovery platform focused on developing medicines that target human metalloenzymes. The company works on a pipeline of therapeutic programs based on this metalloenzyme-targeting approach.

1 investor

FormMed develops and produces micronutrient supplements for individualized health, aimed at physicians, therapists, and alternative practitioners who use them in patient treatment. The products are manufactured in Germany with a focus on scientific quality and bioavailability.

1 investor

Forte Biosciences is a clinical-stage biopharmaceutical company developing FB102, an anti-CD122 monoclonal antibody intended to treat autoimmune diseases including celiac disease, vitiligo, alopecia areata, and type 1 diabetes by modulating immune cell activity.

1 investor

Fortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.

1 investor

Forward Therapeutics develops oral small-molecule medicines targeting inflammation-driven diseases, using a structure-based, data-driven discovery engine to design drugs against validated pathways. The company applies expertise in chemistry, immunology, CNS biology, and clinical development.

1 investor

ForwardVue Pharma develops a long-acting ORAI1 blocker administered by intravitreal injection to treat retinal neovascular disease, with a target dosing of 1-2 injections per year for durability up to 12 months. The company operates in ophthalmic drug development.

1 investor

The Founder-Led Biotech Tour is an event series and networking initiative that connects biotech founders, scientists, investors, and ecosystem partners through in-person and virtual events such as speed networking and co-founder matching. It grew out of the Founder-Led Biotech Summit and supports a new generation of biotech company founders.

1 investor

Foundry BioSciences develops protein language models powered by AI for protein engineering to address aging and longevity. The company serves users, partners, and patients globally through novel protein sequences.

1 investor

Fountain Healthcare Partners is a venture capital fund that provides risk capital and expertise to founders building life sciences companies across specialty pharma, biopharmaceuticals, medical devices, and diagnostics. It invests at seed and early stage in Europe and the United States, with over €425M under management.

1 investor

Fourien develops microfluidics-based instruments and sensors for nanoscale diagnostics and analytical measurements in biotech and pharmaceutical industries. The company uses advanced nanofabrication and electronics assembly to create low-cost, rapid testing solutions.

1 investor

Fred Hutch is a cancer research institute that develops biomarkers, therapies, and stem cell products for research and clinical use, and provides data infrastructure and funding to commercialize discoveries into treatments and spinout companies.

1 investor

Frekil automates real-world evidence generation for pharmaceutical and healthcare research, using AI agents to build patient cohorts, design studies, and generate statistical analyses from existing clinical data. The platform enables epidemiological workflows across drug safety monitoring, comparative effectiveness, label expansion, and trial feasibility assessments.

1 investor